19 May 2013
Keywords: novartis, starts, dermatitis, phase, iii, trial, pharmaceuticals
Article | 15 July 1999
Novartis Pharmaceuticals has commenced Phase III clinical trials ofSDZ ASM 981, a non-steroid cream for the treatment of atopic dermatitis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 July 1999
17 May 2013
© 2013 thepharmaletter.com